Back to investors
ADAR1 CAPITAL MANAGEMENT, LLC
ADAR1 CAPITAL MANAGEMENT, LLC
Latest filing: 2026-06-30
ADAR1 CAPITAL MANAGEMENT, LLC runs ADAR1 CAPITAL MANAGEMENT, LLC and currently holds 277 stock positions, which is more than the average of 230 among the investors we track. The portfolio is valued at approximately $2.19B. Their top holdings are ABVX, PTGX, ROIV, SPY, IMVT. The top five represent 30.0% of reported portfolio weight. ADAR1 CAPITAL MANAGEMENT, LLC ranks #82 out of 1000 investors tracked by Alpha Score. In the most recent quarter, ADAR1 CAPITAL MANAGEMENT, LLC initiated 8 new positions. They added to 44 existing positions. They trimmed 29 positions. Their current best-performing preview position is QURE with returns of +181.71%.
Sign in to enable email alerts for this investor.
Showper page
277 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ABVX ABIVAX SA | 11.01% | $40.83 | $114.95 | +181.53% | Added +29.46% |
 PTGX PROTAGONIST THERAPEUTICS INC | 5.39% | $36.19 | $154.40 | +326.63% | Trimmed -3.35% |
 ROIV ROIVANT SCIENCES LTD | 5.11% | $12.92 | $36.30 | +180.96% | Trimmed -3.92% |
 SPY STATE STR SPDR S&P 500 ETF T | 4.41% | $688.26 | $765.62 | +11.24% | Added +69.99% |
 IMVT IMMUNOVANT INC | 4.11% | $19.70 | $44.37 | +125.23% | Trimmed -13.00% |
 AGIO AGIOS PHARMACEUTICALS INC | 2.19% | $36.10 | $33.09 | -8.34% | Added +815.64% |
 CRNX CRINETICS PHARMACEUTICALS IN | 2.09% | $38.21 | $84.69 | +121.64% | Added +7.26% |
 BOXX EA SERIES TRUST | 1.81% | $106.83 | $117.95 | +10.41% | Held |
 CYTK CYTOKINETICS INC | 1.79% | $54.85 | $76.84 | +40.09% | Trimmed -27.61% |
 SEPN SEPTERNA INC | 1.44% | $9.95 | $40.00 | +302.01% | Trimmed -13.68% |
Showing 1-10 of 277